摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Pentyl-4,5-diamino-1,2,4-triazol | 14624-58-9

中文名称
——
中文别名
——
英文名称
3-Pentyl-4,5-diamino-1,2,4-triazol
英文别名
5-Pentyl-1,2,4-triazole-3,4-diamine
3-Pentyl-4,5-diamino-1,2,4-triazol化学式
CAS
14624-58-9
化学式
C7H15N5
mdl
——
分子量
169.23
InChiKey
RFPNWMGFDUWBDB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    12
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.71
  • 拓扑面积:
    82.8
  • 氢给体数:
    2
  • 氢受体数:
    4

文献信息

  • EP1576093A4
    申请人:——
    公开号:EP1576093A4
    公开(公告)日:2009-07-08
  • 3-DEOXYGLUCOSONE AND SKIN
    申请人:Dynamis Therapeutics, Inc.
    公开号:EP1576093A2
    公开(公告)日:2005-09-21
  • FRUCTOSEAMINE 3 KINASE AND THE FORMATION OF COLLAGEN AND ELASTIN
    申请人:Dynamis Therapeutics, Inc.
    公开号:EP1753861A2
    公开(公告)日:2007-02-21
  • [EN] 3-DEOXYGLUCOSONE AND SKIN<br/>[FR] 3-DESOXYGLUCOSONE ET LA PEAU
    申请人:DYNAMIS THERAPEUTICS INC
    公开号:WO2003089601A2
    公开(公告)日:2003-10-30
    The invention relates to the discovery that 3-deoxyglucosone (3DG) and other alpha-dicarbonyl sugars associated diseases and disorders are present and produced in the skin. Further, the invention relates to the discovery that amadorase, an enzyme that mediates 3DG synthesis, is also present in the skin. Thus, the invention further relates to methods of inhibiting production and function of 3-deoxyglucosone and other alpha­dicarbonyl sugars in skin thereby treating or prevention various diseases, disorders or conditions. Additionally, the invention relates to treatment of various diseases, disorders or conditions associated with or mediated by oxidative stress since 3DG induces ROS and AGEs, which are associated with the inflammatory response caused by oxidative stress.
  • [EN] FRUCTOSEAMINE 3 KINASE AND THE FORMATION OF COLLAGEN AND ELASTIN<br/>[FR] FRUCTOSAMINE-3-KINASE ET LA FORMATION DE COLLAGENE ET D'ELASTINE
    申请人:DYNAMIS THERAPEUTICS INC
    公开号:WO2005079463A2
    公开(公告)日:2005-09-01
    The invention relates to the discovery that levels of collagen and elastin can be modulated by changing the flux through the Amadori Pathway and that copper containing compounds and complexes inhibit the enzyme fructoseamine-3-­kinase.
查看更多